New Insights Into Prostate Cancer Care

Dr. Ashwin Singh Parihar sits down with Dr. Louise Emmett to discuss how post-therapy Lutetium - 177 PSMA SPECT / CT may help predict overall survival in patients with metastatic castration resistant prostate cancer and shape future treatment decisions. Drawing from the ENZA -p trial run by ANZUP cancer trials group, they explore quantitative imaging, treatment response assessment, adaptive dosing…